On 2025-05-15, Forte Biosciences, Inc. (FBRX) announced earnings per share of $-1.37 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.89.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-1.21 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.89 | $-1.37 |
| 2024-11-14 | 2024-09-30 | $-6.75 | $-4.54 |
| 2024-08-14 | 2024-06-30 | $-4.00 | $-6.75 |
| 2024-05-13 | 2024-03-31 | -- | $-4.00 |
| 2024-03-18 | 2023-12-31 | -- | $-1.00 |
| 2023-11-13 | 2023-09-30 | -- | $-6.50 |
| 2023-08-14 | 2023-06-30 | -- | $-10.50 |
| 2023-05-15 | 2023-03-31 | -- | $-8.00 |
| 2023-03-31 | 2022-12-31 | -- | $-6.00 |
| 2022-11-14 | 2022-09-30 | -- | $-4.50 |
| 2022-08-15 | 2022-06-30 | -- | $-5.25 |
| 2022-05-16 | 2022-03-31 | -- | $-4.25 |
| 2022-03-31 | 2021-12-31 | -- | $-5.25 |
| 2021-11-08 | 2021-09-30 | $-7.25 | $-13.50 |
| 2021-08-16 | 2021-06-30 | $-10.00 | $-10.75 |
| 2021-05-10 | 2021-03-31 | $-9.75 | $-9.00 |
| 2020-11-09 | 2020-09-30 | $-8.00 | $-11.50 |
| 2020-08-10 | 2020-06-30 | -- | $-238.00 |
| 2020-04-23 | 2020-03-31 | -- | $-161.17 |
| 2020-02-27 | 2019-12-31 | $-206.15 | $-164.92 |
| 2019-11-12 | 2019-09-30 | $-254.87 | $-292.35 |
| 2019-08-08 | 2019-06-30 | $-281.11 | $-269.87 |
| 2019-05-07 | 2019-03-31 | $-281.11 | $-277.36 |
| 2019-02-27 | 2018-12-31 | $-228.64 | $-359.82 |
| 2018-11-08 | 2018-09-30 | $-89.96 | $-7.50 |
| 2018-08-07 | 2018-06-30 | $-213.64 | $-303.60 |
| 2018-05-10 | 2018-03-31 | -- | $-243.63 |
| 2018-03-08 | 2017-12-31 | $-198.65 | $-206.15 |
| 2017-11-08 | 2017-09-30 | $-179.91 | $-187.41 |
| 2017-08-09 | 2017-06-30 | $-194.90 | $-209.90 |
| 2017-05-23 | 2017-03-31 | $-1011.99 | $-1540.48 |